Biomarker Analysis of Solid Cancers Such as Gastrointestinal Cancer
NCT01831609 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 1000
Last updated 2022-06-15
Summary
To prospectively collect ascites, pleural fluid, circulating tumor cells and derived primary cultures from metastatic cancer patients. The specimens will be analyzed using DNA/RNA/proteomic approaches.
Conditions
- Sarcoma
Sponsors & Collaborators
-
Samsung Medical Center
lead OTHER
Principal Investigators
-
Jeeyun Lee, professor · Samsung Medical Center
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2011-08-31
- Primary Completion
- 2023-12-31
- Completion
- 2024-12-31
Countries
- South Korea
Study Locations
More Related Trials
-
Glycans Bound to Serum Haptoglobin: a Novel Gastric Cancer Tumor Biomarker
NCT02848066 ·Status: COMPLETED
-
AssesSment of Early-deteCtion basEd oN liquiD Biopsy in Hepatobiliary Cancer Malignancies
NCT04835675 ·Status: COMPLETED
-
Circulating Free DNA Analysis in Gastrointestinal Cancer, Genitourinary Cancer, Rare Cancer
NCT02067754 ·Status: COMPLETED
-
Collection of Tissue & Blood From Patients w/ Benign & Malignant Tumors of the Soft Tissue & Gastrointestinal Tract
NCT00582647 ·Status: ACTIVE_NOT_RECRUITING
-
Prospective Procurement of Tumor Tissue to Identify Novel Therapeutic Targets and Study the Tumor Microenvironment
NCT05600933 ·Status: ENROLLING_BY_INVITATION
-
Prospective Collection of Surplus Surgical Tumor Tissues and Pre-surgical Blood Samples
NCT01792882 ·Status: WITHDRAWN
-
Collecting Solid Tumor Tissue to Identify New Treatments
NCT01658917 ·Status: COMPLETED
-
Identification of Secreted Markers for Tumor Hypoxia in Patients With Head and Neck or Lung Cancers
NCT00568490 ·Status: RECRUITING
-
Clinical Sequencing Project for Metastatic Cancer Patients for Personalized Cancer Clinic.
NCT02593578 ·Status: UNKNOWN
-
Liquid Biopsy in Monitoring the Therapeutic Efficacy of Targeted Therapy in Advanced/Metastatic Gastric Cancer
NCT02610218 ·Status: UNKNOWN
-
Liquid Biopsy-informed Precision Oncology Study to Evaluate Utility of Plasma Genomic Profiling for Therapy Selection
NCT05585684 ·Status: RECRUITING
-
Biomarkers in Patients With Head and Neck Cancer and in Healthy Volunteers
NCT00899769 ·Status: COMPLETED
-
Diagnosis of Multiple Cancer and Monitoring of Minimal Residual Tumors After Treatment Using Blood and High-Sensitivity Genetic Analysis Techniques
NCT07035587 ·Status: RECRUITING
-
Collection of Malignant Ascites, Pleural Fluid, and Blood From People With Solid Tumors
NCT03189108 ·Status: TERMINATED
-
Genomics and Prognosis in GI Cancers
NCT05767697 ·Status: RECRUITING
-
Obtaining Solid Tumor Tissue From People Having Biopsy or Surgery for Certain Types of Cancer
NCT01915225 ·Status: RECRUITING
-
Examining Blood and Tissue Samples to Identify Diagnostic Markers in Patients With Metastatic Cancer Undergoing Tumor Removal
NCT05530759 ·Status: RECRUITING
-
Identification of Prognostic Gene Mutations in Biliary Tract Cancer Using Whole Genome Sequencing
NCT03718897 ·Status: UNKNOWN
-
Early Detection of Gastric Cancer Using Plasma Cell-free DNA Fragmentomics
NCT05269056 ·Status: UNKNOWN
-
Development and Validation of Metabolic Biomarkers for Early Diagnosis, Prognosis, and Recurrence of Gastric Cancer：MetBio-GC
NCT07076979 ·Status: RECRUITING
-
Clinical Utility of Selected Circulating Tumor DNA Assays in Patients With Advanced Malignancy
NCT06290856 ·Status: TERMINATED
-
DNA Mutation Detection in Circulating Tumor DNA and Tissue by mmADPS for Pancreatic Cancer
NCT05604573 ·Status: UNKNOWN
-
Next pErsonalized Cancer tX With mulTi-omics and Preclinical Model
NCT02141152 ·Status: COMPLETED
-
Prospective Screening and Differentiating Common Cancers Using Peripheral Blood Cell-Free DNA Sequencing
NCT06036563 ·Status: RECRUITING
-
A Systems Approach to Immunotherapy Biomarker Identification Within the Postoperative Wound-Healing Microenvironment in Patients With Gastroesophageal Cancer
NCT05338060 ·Status: COMPLETED